Beckman Coulter has launched the next analyzer in its growing family of UniCel® systems, the UniCel DxI 600 Access® Immunoassay System. This instrument is designed for mid-volume laboratories, a segment which represents more than 45 percent of the immunodiagnostic testing market, worldwide.
Smiths Medical, part of the Smiths Group, has organised and is maintaining one of four main laboratories for Caudwell Xtreme Everest - the biggest human biology study ever performed at high altitude.
Osmolality is a simple, rapid and relatively inexpensive procedure that is important in the diagnosis of many physiological conditions, because the measurement of osmolality often provides information that cannot be obtained by any other method.
By Henning von Eicke of Roche Diagnostics GmbH
The Sato Corporation specialises in barcode printing - established in Japan, it pioneered the first hand labellers in 1962 and, in 1974, developed a printer able to print barcodes and OCR characters.
Researchers have made a breakthrough by detecting the electrical equivalent of a living cell's last gasp. The work takes them a step closer to both seeing the 'heartbeat' of a living cell and a new way to test drugs.
The methicillin resistant staphylococcus aureus (MRSA) is one of the most common causes of life threatening infections among hospital patients. What makes the bacterium that dangerous is the fact, that due to unspecific symptoms and long lasting testing procedures its detection takes too long. A new test that delivers results in just five hours now offers the possibility of a MRSA screening for…
A new testing approach has effectively identified patients at the highest risk of cancer relapse after bladder cancer surgery, according to a study published in the February issue of The Lancet Oncology http://oncology.thelancet.com. Vol 8 Feb 2007 91.
Human genetic testing centre gains international quality accreditation.
Beckman Coulter developed a new integrated lab systems: The UniCel DxC880i prototype should deliver efficient disease management services.
A new blood test is under development that has detected two kinds of proteins found in people suffering Alzheimer's.
Inverness Medical Innovations develops and manufactures rapid diagnostic products for use in preventive as well as interventional therapies.
Rigel Medical, part of the Seaward Group, has launched a new biomedical electrical safety analyser.
AstraZeneca has been collaborating with researchers who detected a potential Aurora B inhibitor.
Community-acquired pneumonia (CAP) is a major health problem globally. A new test now quickly identify pathogens. BinaxNOW tests quickly identify pathogens
Bologna - The University Hospital S.Orsola-Malpighi has 1,800 beds and is one of the largest to install the DNLab management system. With 150 workstations connected to the LIS and over 50 analysers, each day, the two laboratories (central and microbiology) receive almost 3,000 orders and carry out over nine million tests annually. Hospital wards and departments are connected via Web to the LIS…
Hospitals increasingly co-operate with other establishments, and networking is becoming a way of life. Such change is also occurring in many hospital laboratories. By co-operating with other hospital labs and laboratory institutes, hospital labs try to improve their financial situation. By Dr Burkhard Ziebolz of Roche Diagnostics GmbH
An unparalleled legal challenge has been underway in the EU regarding the number of human gene patents held by US-based corporation Myriad Genetics.
USA - A new laboratory test - EGFRx, developed by the Weisenthal Cancer Group* - has accurately identified patients who would benefit from treatment with the molecularly-targeted anti-cancer therapies gefitinib (Iressa, AstraZeneca) and erlotinib (Tarceva, Genentech), according to clinical data published at the annual meeting of the American Society of Clinical Oncology (ASCO).
USA - A new technology, named glycan microarray, can identify pathogens in a few hours and give advance warning of the ability of a virus to infect humans.
Downloading digitally signed clinical test results from home is possible and 40% of users residing in the Treviso region in Veneto, do so regularly.
The Innsbruck Biocentre, led by Professor Lukas Huber, is involved in a major European research project. This involves the development of a 'biological interface' for a new semiconductor developed by Siemens.
The development of diagnostic products and systems has paralleled the development of new technologies in fields such as biology, electronics and computer science.
